Asmaa Khattab, N. Awad, Doaa A. Abdel Fadeel, M. Fadel
{"title":"Reviewing the reported pharmacognostic and pharmacological investigations on Tecoma stans Juss. ex Kunth","authors":"Asmaa Khattab, N. Awad, Doaa A. Abdel Fadeel, M. Fadel","doi":"10.34172/jhp.2023.03","DOIUrl":null,"url":null,"abstract":"This review is destined for a comprehensive assessment of the phytochemistry and medicinal properties of Tecoma stans, a widely used plant in folk cultures, as a traditionally safe and effective treatment for different diseases and complications. The attainable and reachable sources of T. stans confirmed its origin, ethnopharmacological properties, and therapeutic medicinal uses. Besides a hundred chemical compounds that have been isolated, the main active constituents are flavonoids, alkaloids, phenolic acids, and fatty acids. T. stans exerted many medicinal benefits, including antidiabetic, anti-inflammatory, anti-cancer, antimicrobial, antioxidant, hepatoprotective, cardioprotective, and nephroprotective properties. However, there is a shortage of in vivo studies, especially adequate dosage and toxicity studies. More studies should be carried out for nutritional data. This review represents a scientific understanding of clinical correlations and applications of phytocompounds from T. stans in protecting and treating many complaints and disorders.","PeriodicalId":15934,"journal":{"name":"Journal of HerbMed Pharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of HerbMed Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jhp.2023.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
This review is destined for a comprehensive assessment of the phytochemistry and medicinal properties of Tecoma stans, a widely used plant in folk cultures, as a traditionally safe and effective treatment for different diseases and complications. The attainable and reachable sources of T. stans confirmed its origin, ethnopharmacological properties, and therapeutic medicinal uses. Besides a hundred chemical compounds that have been isolated, the main active constituents are flavonoids, alkaloids, phenolic acids, and fatty acids. T. stans exerted many medicinal benefits, including antidiabetic, anti-inflammatory, anti-cancer, antimicrobial, antioxidant, hepatoprotective, cardioprotective, and nephroprotective properties. However, there is a shortage of in vivo studies, especially adequate dosage and toxicity studies. More studies should be carried out for nutritional data. This review represents a scientific understanding of clinical correlations and applications of phytocompounds from T. stans in protecting and treating many complaints and disorders.
期刊介绍:
Journal of Herbmed Pharmacology (J Herbmed Pharmacol) is the intersection between medicinal plants and pharmacology. This international journal publishes manuscripts in the fields of medicinal plants, pharmacology and therapeutic. This journal aims to reach all relevant national and international medical institutions and persons in electronic version free of charge. J Herbmed Pharmacol has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists. In addition, J Herbmed Pharmacol welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical pharmacology. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.